» Articles » PMID: 39195995

Extensive Identification of Genes Involved in Congenital and Structural Heart Disorders and Cardiomyopathy

Overview
Publisher Springer Nature
Date 2024 Aug 28
PMID 39195995
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical presentation of congenital heart disease is heterogeneous, making identification of the disease-causing genes and their genetic pathways and mechanisms of action challenging. By using in vivo electrocardiography, transthoracic echocardiography and microcomputed tomography imaging to screen 3,894 single-gene-null mouse lines for structural and functional cardiac abnormalities, here we identify 705 lines with cardiac arrhythmia, myocardial hypertrophy and/or ventricular dilation. Among these 705 genes, 486 have not been previously associated with cardiac dysfunction in humans, and some of them represent variants of unknown relevance (VUR). Mice with mutations in Casz1, Dnajc18, Pde4dip, Rnf38 or Tmem161b genes show developmental cardiac structural abnormalities, with their human orthologs being categorized as VUR. Using UK Biobank data, we validate the importance of the DNAJC18 gene for cardiac homeostasis by showing that its loss of function is associated with altered left ventricular systolic function. Our results identify hundreds of previously unappreciated genes with potential function in congenital heart disease and suggest causal function of five VUR in congenital heart disease.

Citing Articles

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.

Rasooly D, Giambartolomei C, Peloso G, Dashti H, Ferolito B, Golden D Nat Cardiovasc Res. 2025; .

PMID: 39915329 DOI: 10.1038/s44161-025-00609-1.


IMPC impact on preclinical mouse models.

Holter S, Cacheiro P, Smedley D, Lloyd K Mamm Genome. 2025; .

PMID: 39820486 DOI: 10.1007/s00335-025-10104-4.


Twenty-first century mouse genetics is again at an inflection point.

Fang Z, Peltz G Lab Anim (NY). 2024; 54(1):9-15.

PMID: 39592878 PMC: 11695262. DOI: 10.1038/s41684-024-01491-3.


Beyond genomic studies of congenital heart defects through systematic modelling and phenotyping.

Henderson D, Alqahtani A, Chaudhry B, Cook A, Eley L, Houyel L Dis Model Mech. 2024; 17(11).

PMID: 39575509 PMC: 11603121. DOI: 10.1242/dmm.050913.


The mitochondrial citrate carrier SLC25A1 regulates metabolic reprogramming and morphogenesis in the developing heart.

Ohanele C, Peoples J, Karlstaedt A, Geiger J, Gayle A, Ghazal N Commun Biol. 2024; 7(1):1422.

PMID: 39482367 PMC: 11528069. DOI: 10.1038/s42003-024-07110-8.


References
1.
Shan J, Pang S, Wanyan H, Xie W, Qin X, Yan B . Genetic analysis of the SIRT1 gene promoter in ventricular septal defects. Biochem Biophys Res Commun. 2012; 425(4):741-5. DOI: 10.1016/j.bbrc.2012.07.145. View

2.
Gelb B, Brueckner M, Chung W, Goldmuntz E, Kaski J, Kim R . The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res. 2013; 112(4):698-706. PMC: 3679175. DOI: 10.1161/CIRCRESAHA.111.300297. View

3.
Herman D, Lam L, Taylor M, Wang L, Teekakirikul P, Christodoulou D . Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012; 366(7):619-28. PMC: 3660031. DOI: 10.1056/NEJMoa1110186. View

4.
Fu K, Nakano H, Morselli M, Chen T, Pappoe H, Nakano A . A temporal transcriptome and methylome in human embryonic stem cell-derived cardiomyocytes identifies novel regulators of early cardiac development. Epigenetics. 2018; 13(10-11):1013-1026. PMC: 6342070. DOI: 10.1080/15592294.2018.1526029. View

5.
Landstrom A, Dobrev D, Wehrens X . Calcium Signaling and Cardiac Arrhythmias. Circ Res. 2017; 120(12):1969-1993. PMC: 5607780. DOI: 10.1161/CIRCRESAHA.117.310083. View